CoChat

Research in people with psychosis risk syndrome: a review of the current evidence and future directions

Open access
Correll, Christoph U., Hauser, Marta, Auther, Andrea M., Cornblatt, Barbara A. · 2010 · Journal of Child Psychology and Psychiatry
Cited by 194

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

After decades of research, schizophrenia and related psychotic disorders are still among the most debilitating disorders in medicine. The chronic illness course in most individuals, greater treatment responsiveness during the first episode, progressive gray matter decline during early disease stages, and retrospective accounts of ‘prodromal’ or early illness signs and symptoms formed the basis for research on the psychosis risk syndrome (PRS), known variably as ‘clinical high risk’ (CHR), or ‘ultra‐high risk’ (UHR), or ‘prodromal’. The pioneering era of research on PRS focused on the development and validation of specific assessment tools and the delineation of high risk criteria. This was followed by the examination of conversion rates in psychosis risk cohorts followed naturalistically, identification of predictors of conversion to psychosis, and investigation of interventions able to abort or delay the development of full psychosis. Despite initially encouraging results concerning the predictive validity of PRS criteria, recent findings of declining conversion rates demonstrate the need for further investigations. Results from intervention studies, mostly involving second‐generation antipsychotics and cognitive behavioral therapy, are encouraging, but are currently still insufficient to make treatment recommendations for this early, relatively non‐specific illness phase. The next phase of research on PRS, just now beginning, has moved to larger, ‘multisite’ projects to increase generalizability and to ensure that sufficiently large samples at true risk for psychosis are included. Emphasis in these emerging studies is on: 1) identification of biomarkers for conversion to psychosis; 2) examination of non‐antipsychotic, neuroprotective and low‐risk pharmacologic and non‐pharmacologic interventions; 3) testing of potentially phase‐specific interventions; 4) examination of the relationship between treatment response during PRS and prognosis for the course of illness; 5) follow‐up of patients who developed schizophrenia despite early interventions and comparison of illness trajectories with patients who did not receive early interventions; 6) characterization of individuals with outcomes other than schizophrenia‐spectrum disorders, such as bipolar disorder and remission from PRS, including false positive cases; and 7) assessment of meaningful social and role functioning outcomes. While the research conducted to date has already yielded crucial information, the translation of the concept of a clinically identifiable PRS into clinical practice does not seem justified at this point.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1469-7610.2010.02235.x

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Cited by

See all 194

Metadata

Authors
Correll, C. U., Hauser, M., Auther, A. M., & Cornblatt, B. A.
Venue
Journal of Child Psychology and Psychiatry
Publisher
Wiley
Published
2010-03-11
Volume
51
Issue
4
Pages
390-431
ISSN
  • 0021-9630 (ISSN-L)
  • 1469-7610
OpenAlex
W2123369382
Cited by
194
References
41
FWCI
16.15
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Research in people with psychosis risk syndrome: a review of the current evidence and future directions. https://app.cochat.ai/papers/10.1111/j.1469-7610.2010.02235.x
The paper
Correll, C. U., Hauser, M., Auther, A. M., & Cornblatt, B. A. (2010). Research in people with psychosis risk syndrome: a review of the current evidence and future directions. Journal of Child Psychology and Psychiatry. https://doi.org/10.1111/j.1469-7610.2010.02235.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.